Haemonetics (HAE) Tops Q3 EPS by 3c; Offers Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.52 --0%
Revenue Growth %: +5.5%
Financial Fact:
Net income: 19.83M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +5.5%
Financial Fact:
Net income: 19.83M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $0.85, $0.03 better than the analyst estimate of $0.82. Revenue for the quarter came in at $305.3 million versus the consensus estimate of $299.08 million.
GUIDANCE:
Haemonetics sees FY2023 EPS of $2.90-$3.00, versus the consensus of $2.92.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Getty Realty (GTY) Reiterated at Market Outperform by Citizens on Investment Volumes
- AutoZone beats profit view but misses on revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
